Procter & Gamble (NYSE:PG) Stock Price Down 0.1% – Should You Sell?

The Procter & Gamble Company (NYSE:PGGet Free Report)’s share price traded down 0.1% during mid-day trading on Monday . The stock traded as low as $168.83 and last traded at $169.35. 971,485 shares changed hands during mid-day trading, a decline of 85% from the average session volume of 6,651,275 shares. The stock had previously closed at $169.54.

Analysts Set New Price Targets

Several research analysts have issued reports on the stock. DA Davidson lifted their target price on shares of Procter & Gamble from $159.00 to $160.00 and gave the stock a “neutral” rating in a report on Monday, October 21st. Barclays cut shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 target price for the company. in a report on Monday, September 30th. TD Cowen assumed coverage on shares of Procter & Gamble in a report on Tuesday, July 23rd. They set a “buy” rating and a $189.00 price objective for the company. Piper Sandler assumed coverage on shares of Procter & Gamble in a research report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 target price for the company. Finally, JPMorgan Chase & Co. boosted their target price on shares of Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research report on Thursday, September 19th. Nine analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $177.00.

View Our Latest Research Report on PG

Procter & Gamble Trading Up 1.1 %

The firm has a market cap of $403.56 billion, a PE ratio of 29.20, a P/E/G ratio of 3.67 and a beta of 0.42. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The company’s 50 day moving average price is $170.32 and its two-hundred day moving average price is $168.40.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. The firm had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The business’s revenue for the quarter was down .6% on a year-over-year basis. During the same period in the prior year, the business posted $1.83 earnings per share. As a group, sell-side analysts forecast that The Procter & Gamble Company will post 6.94 EPS for the current year.

Procter & Gamble Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were issued a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.35%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble’s payout ratio is presently 69.48%.

Insiders Place Their Bets

In other Procter & Gamble news, CEO Jon R. Moeller sold 37,240 shares of the stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $168.89, for a total transaction of $6,289,463.60. Following the transaction, the chief executive officer now directly owns 263,537 shares in the company, valued at $44,508,763.93. This represents a 12.38 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Shailesh Jejurikar sold 10,623 shares of the stock in a transaction dated Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total transaction of $1,797,624.06. Following the transaction, the chief operating officer now owns 23,890 shares in the company, valued at approximately $4,042,665.80. The trade was a 30.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 313,597 shares of company stock worth $53,268,499 in the last three months. Corporate insiders own 0.18% of the company’s stock.

Institutional Trading of Procter & Gamble

A number of institutional investors have recently modified their holdings of the company. Itau Unibanco Holding S.A. purchased a new position in shares of Procter & Gamble in the 2nd quarter valued at approximately $28,000. Fairway Wealth LLC purchased a new position in shares of Procter & Gamble in the 2nd quarter valued at approximately $29,000. RPg Family Wealth Advisory LLC purchased a new position in shares of Procter & Gamble in the 3rd quarter valued at approximately $33,000. POM Investment Strategies LLC purchased a new position in shares of Procter & Gamble in the 2nd quarter valued at approximately $34,000. Finally, Quest Partners LLC purchased a new position in shares of Procter & Gamble in the 2nd quarter valued at approximately $36,000. 65.77% of the stock is currently owned by institutional investors.

Procter & Gamble Company Profile

(Get Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Further Reading

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.